These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452 [TBL] [Abstract][Full Text] [Related]
6. Posttransplant diabetes in pediatric recipients on tacrolimus. Shapiro R; Scantlebury V; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Fung JJ; Simmons RL; Starzl TE Transplantation; 1999 Mar; 67(5):771. PubMed ID: 10096540 [No Abstract] [Full Text] [Related]
7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
8. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant. Keshavarz R; Mousavi MA; Hassani C Pediatr Emerg Care; 2002 Feb; 18(1):22-4. PubMed ID: 11862133 [TBL] [Abstract][Full Text] [Related]
9. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602 [TBL] [Abstract][Full Text] [Related]
10. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351 [TBL] [Abstract][Full Text] [Related]
11. Improving results of pediatric renal transplantation. Shapiro R; Tzakis A; Scantlebury V; Jordan M; Vivas C; Ellis D; Gilboa N; Irish W; Hopp L; Reyes J J Am Coll Surg; 1994 Oct; 179(4):424-32. PubMed ID: 7522851 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Miller J; Mendez R; Pirsch JD; Jensik SC Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543 [TBL] [Abstract][Full Text] [Related]
13. Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. Gruessner RW; Sutherland DE; Najarian JS; Dunn DL; Gruessner AC Transplantation; 1997 Dec; 64(11):1572-7. PubMed ID: 9415558 [TBL] [Abstract][Full Text] [Related]
14. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus. Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716 [TBL] [Abstract][Full Text] [Related]
16. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Hoitsma AJ; Hilbrands LB Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494 [TBL] [Abstract][Full Text] [Related]
17. Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment. Dittrich K; Knerr I; Rascher W; Dötsch J Pediatr Nephrol; 2006 Jul; 21(7):958-61. PubMed ID: 16773407 [TBL] [Abstract][Full Text] [Related]
18. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation. Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766 [TBL] [Abstract][Full Text] [Related]
19. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Roberts CA; Stern DL; Radio SJ Transplantation; 2002 Sep; 74(6):817-21. PubMed ID: 12364862 [TBL] [Abstract][Full Text] [Related]
20. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]